跳至主要内容
临床试验/IRCT20191106045350N1
IRCT20191106045350N1已完成3 期

Comparison of the effects of Pramipexole and Gabapentin on the treatment of restless leg syndrome in end-stage chronic renal failure patients undergoing hemodialysis

Qazvin University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with end-stage chronic renal failure (at least 6 months) under permanent hemodialysis
  • Having restless legs syndrome (RLS) based on International RLS Study Group (IRSLSS) diagnostic criteria
  • Moderate to severe RLS based on IRSLSS diagnostic criteria

排除标准

  • Iron deficiency anemia
  • Concomitant neurodegenerative diseases such as cerebrovascular accident (CVA) and Parkinson's disease
  • Lyme disease
  • Complications such as nausea, vomiting, and abdominal pain due to medication use

研究者

相似试验